These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7482309)

  • 21. [Effect of octreotide on the clinical course of acute pancreatitis and levels of free oxygen radicals and antioxidants].
    Lata J; Dítĕ P; Julínková K; Precechtĕlová M; Prásek J
    Vnitr Lek; 1998 Sep; 44(9):524-7. PubMed ID: 10358462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous subcutaneous octreotide in gastrointestinal cancer patients: pain control and beta-endorphin levels.
    Befon S; Mystakidou K; Lyra M; Tubanakis N; Vlahos L
    Anticancer Res; 2000; 20(5C):4039-46. PubMed ID: 11268498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The administration of sandostatin in the combined treatment of acute pancreatitis and its complications].
    Saenko VF; Lupal'tsov VI; Babenkov GF; Kopchak VM; Volzhanskiĭ AP
    Klin Khir; 1999; (10):5-7. PubMed ID: 10584505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
    Wu SF; Chen AC; Peng CT; Wu KH
    Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental study on the therapeutic effects of SMS201-995 on bile-induced acute pancreatitis in the dog].
    Satoh M
    Hokkaido Igaku Zasshi; 1998 Jan; 73(1):37-46. PubMed ID: 9546145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of octreotide on acute pancreatitis of varying severity in rats.
    Küçüktülü U; Alhan E; Erçin C; Cinel A; Calik A
    Eur J Surg; 1999 Sep; 165(9):891-6. PubMed ID: 10533767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of octreotide and somatostatin in acute and chronic pancreatitis.
    Uhl W; Anghelacopoulos SE; Friess H; Büchler MW
    Digestion; 1999; 60 Suppl 2():23-31. PubMed ID: 10207228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats.
    Paran H; Klausner J; Siegal A; Graff E; Freund U; Kaplan O
    J Surg Res; 1996 May; 62(2):201-6. PubMed ID: 8632640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Octreotide prevents L-asparaginase-induced pancreatic injury in rats.
    Suzuki M; Shimizu T; Kudo T; Shoji H; Ohtsuka Y; Yamashiro Y
    Exp Hematol; 2008 Feb; 36(2):172-80. PubMed ID: 18023522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of pancreatic insufficiency with a preparation containing high lipase activity].
    Pap A; Szilágyi V; Marosi E
    Orv Hetil; 1997 Mar; 138(10):601-4. PubMed ID: 9157336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes of somatostatin receptor of pancreas and effectiveness of octreotide on acute necrotizng pancreatitis in mice].
    Wu J; Yuan Y; Xu J
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(12):740-3. PubMed ID: 11798959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the effectiveness of the preparation Panzytrat 20,000 U in the substitute treatment of chronic pancreatitis].
    Rydzewska G; Turecka-Kulesza E; Ciok J; Pietrzak J; Gabryelewicz A; Butruk E; Dzieniszewski J
    Wiad Lek; 1994 Oct; 47(19-20):738-44. PubMed ID: 7483619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis.
    Safdi M; Bekal PK; Martin S; Saeed ZA; Burton F; Toskes PP
    Pancreas; 2006 Aug; 33(2):156-62. PubMed ID: 16868481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of octreotide on gastric mucosal massive hemorrhage in patients with portal hypertensive gastropathy].
    Le Q; Zhang J; Xu Q; Gao H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):68. PubMed ID: 11856512
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
    Penning C; Vecht J; Masclee AA
    Aliment Pharmacol Ther; 2005 Nov; 22(10):963-9. PubMed ID: 16268971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
    Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.